Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21569Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sotiriadis, A. | en |
| dc.contributor.author | Makrigiannakis, A. | en |
| dc.contributor.author | Stefos, T. | en |
| dc.contributor.author | Paraskevaidis, E. | en |
| dc.contributor.author | Kalantaridou, S. N. | en |
| dc.date.accessioned | 2015-11-24T19:15:50Z | - |
| dc.date.available | 2015-11-24T19:15:50Z | - |
| dc.identifier.issn | 0029-7844 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21569 | - |
| dc.rights | Default Licence | - |
| dc.subject | Abortion, Habitual/*physiopathology | en |
| dc.subject | Case-Control Studies | en |
| dc.subject | Child | en |
| dc.subject | Factor XII/*analysis/genetics | en |
| dc.subject | Factor XII Deficiency/epidemiology/physiopathology | en |
| dc.subject | Factor XIII/genetics | en |
| dc.subject | Female | en |
| dc.subject | Fibrinolysis/*physiology | en |
| dc.subject | Gestational Age | en |
| dc.subject | Humans | en |
| dc.subject | Odds Ratio | en |
| dc.subject | Plasminogen Activator Inhibitor 1/genetics | en |
| dc.subject | Polymorphism, Genetic | en |
| dc.subject | Pregnancy | en |
| dc.title | Fibrinolytic defects and recurrent miscarriage: a systematic review and meta-analysis | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1097/01.AOG.0000260873.94196.d6 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/17470597 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2007 | - |
| heal.abstract | OBJECTIVE: To systematically review evidence of the association between fibrinolytic defects and recurrent miscarriage. DATA SOURCES: MEDLINE, EMBASE, and references of retrieved articles (last update September 2006) were used. METHODS OF STUDY SELECTION: Studies comparing the prevalence of fibrinolytic defects in patients with recurrent miscarriage and control women were reviewed. Of 111 potentially relevant studies, data from 14 were integrated with meta-analytic techniques and were presented as odds ratios (ORs). TABULATION, INTEGRATION, AND RESULTS: Plasminogen activator inhibitor-1 4G/5G polymorphism (OR 1.65, 95% confidence interval [CI] 0.92-2.95) and increased plasminogen activator inhibitor activity were not significantly associated with recurrent miscarriage, although the latter showed profound heterogeneity across studies. Although factor XII C46T polymorphism is not associated with recurrent miscarriage (OR 1.07, 95% CI 0.52-2.22), factor XII deficiency is significantly associated (five studies, 1,096 women; OR 18.11, 95% CI 5.52-59.39), with minimal heterogeneity across studies. Factor XIII Val34Leu and Tyr204Phe polymorphisms were not associated with recurrent miscarriage (OR 1.24, 95% CI 0.46-3.34 and OR 2.61, 95% CI 0.45-15.16, respectively). There were no eligible studies found for the rest of the factors searched (urokinase-type plasminogen activator, tissue-type plasminogen activator, kallicrein, a2-antiplasmin, a2-macroglobulin, thrombin-activated thrombolysis inhibitor, and factor XI). Only a small minority of studies ascertained miscarriage according to specific criteria, and none of the studies provided equal examination for confounders in cases and controls. CONCLUSION: Factor XII deficiency is associated with recurrent miscarriage. Data on the other factors either fail to show association or are quite limited. | en |
| heal.journalName | Obstet Gynecol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
